Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Schisandra chinensis blood-activating formula
- Development stage
- Unknown
- Lead developer
- Shanghai Children’s Hospital
- Administration
- Oral
01
Overview
Schisandra chinensis blood-activating formula is a Traditional Chinese Medicine (TCM) herbal composition developed by Shanghai Children's Hospital for the treatment of pediatric primary nephrotic syndrome. The formula is based on the TCM principle of "activating blood" (Huo Xue) to improve renal microcirculation and "tonifying the kidney" to reduce proteinuria. It is primarily investigated as an adjunctive therapy to be used in combination with Western immunosuppressants like rituximab to reduce relapse rates and improve clinical efficacy in children with hormone-dependent minimal change disease. The titular ingredient, *Schisandra chinensis* (Wuweizi), is known for its immunomodulatory, antioxidant, and anti-inflammatory properties, which are thought to help stabilize the glomerular filtration barrier and mitigate the side effects of long-term steroid or immunosuppressive therapy.
- Other names
- Wuwei Zi Huoxue FangSchisandra chinensis Blood-Activating Formula
02
Targets
AMPK (Adenosine monophosphate–activated protein kinase)CYP2E1CYP3A (CYP3A family)GPIIb/IIIa (Integrin alpha-IIb/beta-3)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)SGLT2 (Sodium-glucose cotransporter protein subunit 2)
Beyond the preview
Go deeper on Schisandra chinensis blood-activating formula.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Schisandra chinensis blood-activating formula.